{
  "type": "hyp",
  "text": "However CsA and other CsA inhibitors inhibit the appearance of DNA binding activity of factors that bind to the NF-AT and AP-1 sites in the IL-2 enhancer.\n",
  "self": {
    "NER": {
      "answers": [
        "IL-2"
      ],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": [
          "What enhancer does CsA inhibit?"
        ]
      }
    },
    "NOUN": {
      "answers": [
        "CsA",
        "other CsA inhibitors",
        "the appearance",
        "DNA binding activity",
        "factors",
        "the NF-AT",
        "AP-1 sites",
        "the IL-2 enhancer"
      ],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": [
          "What is an inhibitor of DNA binding?",
          "What inhibits the appearance of DNA binding activity of factors that bind to the NF-",
          "What does CsA inhibit?",
          "What does CsA inhibit?",
          "What does CsA inhibit the appearance of DNA binding activity of?",
          "What is the name of the binder that CsA inhibits?",
          "What two sites in the IL-2 enhancer do CsA inhibit?",
          "What site does CsA inhibit the appearance of DNA binding activity of?"
        ]
      }
    }
  },
  "asked": {
    "What inhibits the appearance of DNA binding activity of factors that bind to the NF-": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "CsA and other CsA inhibitors",
        "answerability": 0.834290623664856,
        "ground_truth": {
          "FK506": {
            "bertscore": 0.6523043513298035,
            "f1": 0
          },
          "CsA": {
            "bertscore": 0.7525781393051147,
            "f1": 0.33333333333333337
          }
        }
      }
    },
    "What enhancer does CsA and FK506 inhibit?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.04703021049499512,
        "ground_truth": {
          "IL-2": {
            "bertscore": 0.6760645508766174,
            "f1": 0
          }
        }
      }
    },
    "What does CsA and FK506 inhibit?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.10579782724380493,
        "ground_truth": {
          "the appearance": {
            "bertscore": 0.6999257802963257,
            "f1": 0
          }
        }
      }
    },
    "What do CsA and FK506 inhibit?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.10326296091079712,
        "ground_truth": {
          "DNA binding activity": {
            "bertscore": 0.6785699129104614,
            "f1": 0
          }
        }
      }
    },
    "What does CsA and FK506 inhibit the appearance of DNA binding activity of?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.24852609634399414,
        "ground_truth": {
          "factors": {
            "bertscore": 0.6932956576347351,
            "f1": 0
          }
        }
      }
    },
    "What is the name of the molecule that binds to IL-2?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.02237570285797119,
        "ground_truth": {
          "the NF-AT": {
            "bertscore": 0.6778975129127502,
            "f1": 0
          }
        }
      }
    },
    "What two sites in the IL-2 enhancer do CsA and FK506": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.21694153547286987,
        "ground_truth": {
          "AP-1 sites": {
            "bertscore": 0.664882481098175,
            "f1": 0
          }
        }
      }
    },
    "What is the NF-AT and AP-1 sites in?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "IL-2 enhancer",
        "answerability": 0.9432355761528015,
        "ground_truth": {
          "the IL-2 enhancer": {
            "bertscore": 0.9470422863960266,
            "f1": 1.0
          }
        }
      }
    }
  }
}